BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31159646)

  • 1. Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Townsend M; DeWees T; Gross J; Daly M; Gay H; Thorstad W; Jackson RS
    Otolaryngol Head Neck Surg; 2019 Aug; 161(2):297-306. PubMed ID: 31159646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy.
    Heiduschka G; Grah A; Oberndorfer F; Kadletz L; Altorjai G; Kornek G; Wrba F; Thurnher D; Selzer E
    Strahlenther Onkol; 2015 Mar; 191(3):209-16. PubMed ID: 25252603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma.
    Lee NCJ; Kelly JR; Park HS; An Y; Judson BL; Burtness BA; Husain ZA
    Oral Oncol; 2018 Oct; 85():35-39. PubMed ID: 30220317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Radiation Therapy Refusal in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Prasad A; Carey RM; Brody RM; Bur AM; Cannady SB; Ojerholm E; Newman JG; Ibrahim S; Brant JA; Rajasekaran K
    Laryngoscope; 2022 Feb; 132(2):339-348. PubMed ID: 34254672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
    Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
    Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
    Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
    Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
    Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
    Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
    Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage.
    Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL
    Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of postoperative radiation dose in the management of human papillomavirus-positive oropharyngeal cancer.
    Chin RI; Spencer CR; DeWees T; Hwang MY; Patel P; Sinha P; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Lewis JS; Thorstad WL
    Head Neck; 2016 Nov; 38(11):1643-1649. PubMed ID: 27152851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of postoperative radiotherapy in patients with oropharyngeal squamous cell carcinoma in human papillomavirus (HPV) era: A Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Kwak MS; Eun YG; Lee YC
    Surgery; 2021 Aug; 170(2):541-549. PubMed ID: 33663877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
    Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
    Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of adjuvant radiation and survival in human papilloma virus-positive oropharynx squamous cell carcinoma with lymphovascular invasion as the sole adverse pathologic feature.
    Hong SA; Armstrong AT; Snow K; Walker RJ; Massa ST
    Head Neck; 2024 May; 46(5):1043-1050. PubMed ID: 38511301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.